Boston Scientific Corp

Healthcare · Medical Devices

44.70$ +0.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Boston Scientific Corp (BSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 5,442 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BSX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	2,105	2,191	2,160	2,257	2,222	2,408	2,379	2,490	2,393	2,561	2,493	2,631	2,707	2,905	2,543	2,003	2,659	2,708	2,752	3,077	2,932	3,127	3,026	3,244	3,170	3,242	3,389	3,599	3,527	3,725	3,856	4,120	4,209	4,561	4,663	5,061	5,065	5,286	5,203	5,442	20,996
Cost of Revenue	743	760	803	789	779	800	791	860	808	885	899	935	977	1,078	1,030	1,016	1,086	1,207	1,085	1,135	1,100	1,186	1,183	1,256	1,242	1,287	1,312	1,323	1,360	1,413	1,472	1,535	1,561	1,890	1,713	1,637	1,523	1,348	1,590	1,594	6,055
Gross Profit	1,362	1,431	1,357	1,468	1,443	1,608	1,588	1,630	1,585	1,676	1,594	1,696	1,730	1,827	1,513	987	1,573	1,501	1,667	1,942	1,832	1,941	1,843	1,988	1,928	1,955	2,077	2,276	2,167	2,312	2,384	2,585	2,648	2,671	2,950	3,424	3,542	3,937	3,613	3,848	14,940
Research & Development	232	256	235	244	254	264	261	275	289	288	280	280	306	309	300	242	315	286	276	298	310	320	319	335	339	330	337	359	356	363	366	383	407	460	443	526	514	569	516	554	2,153
Selling, General & Administrative	772	831	794	815	800	886	860	886	870	953	869	968	1,012	1,092	978	798	984	1,027	1,013	1,121	1,066	1,153	1,060	207	1,152	207	207	207	1,242	1,379	1,364	1,446	1,562	1,612	1,597	1,716	1,741	1,834	1,781	1,803	7,159
Total Operating Expenses	1,026	1,113	1,049	1,073	1,067	1,164	1,131	1,183	1,174	1,252	1,165	1,265	1,333	1,418	1,290	1,048	1,311	1,327	1,307	1,431	1,390	1,484	1,386	1,511	1,468	1,506	1,562	1,725	1,609	1,754	1,740	1,838	1,974	2,082	2,054	2,605	2,492	2,731	2,541	2,670	10,434
Operating Income	336	318	308	395	376	444	457	447	411	424	429	431	397	409	223	-61	262	174	360	511	442	457	457	477	460	449	515	551	558	558	644	747	674	589	896	819	1,050	1,206	1,072	1,178	4,506
Interest Expense	58	58	57	58	57	56	61	64	68	74	114	98	106	189	93	96	91	96	89	88	86	88	295	64	65	64	67	71	67	67	72	81	83	139	87	90	87	90	90	96	363
Pre-Tax Income	257	89	305	91	309	227	323	347	456	296	457	145	91	-6.0	22	-181	-227	248	325	149	483	120	156	345	245	396	445	426	609	505	608	420	668	585	805	941	939	700	1,162	1,060	3,861
Income Tax Expense	29	-35	15	-55	26	842	26	-209	24	-90	33	-9.0	-35	-4,002	12	-33	-72	96	-16	-37	64	26	45	85	57	256	131	156	105	1.0	115	98	200	23	133	146	183	31	-176	155	193
Net Income	228	124	290	146	283	-615	298	555	432	386	424	154	126	3,996	11	-147	-155	152	341	186	419	94	111	260	188	140	314	270	504	504	494	324	469	566	674	793	755	668	1,337	907	3,667
EBITDA	518	361	568	356	576	506	594	627	747	615	800	477	454	476	392	191	145	633	682	500	841	498	725	692	593	757	796	795	976	885	984	812	1,058	1,071	1,217	1,367	1,368	1,155	1,603	1,389	5,515

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings